Poisoning or drug overdose recently surpassed motor vehicle crash as the number one cause of injury-related death in the United States. There has been a rapid increase in fatal overdose since the mid-1990’s which is largely attributable to the increase in prescribed opioids as well as prescription opioid misuse and abuse. Additionally, heroin-related overdose deaths are also increasing and many new-initiates of heroin report first misusing prescription opioids. Along with this rise in fatal overdose, there has also been an increase in opioid related ED visits secondary to non-fatal overdose or misuse.
The distribution of naloxone, an opioid agonist, has been associated with a with a decline in fatal overdoses in population based studies, has been long used by community-based/public health programs and is increasingly used in medical settings including primary care and emergency departments. This webinar discusses recent research and programs on provision of take-home naloxone to ED patients at risk for opioid overdose, as part of a strategy to reduce opioid related harms and substance abuse. Lastly, it highlights a successful take-home Naloxone program to discuss the real-world application and implementation of a take-home Naloxone program.
Panelists Include: Michael Botticelli – Acting Director of the White House ONDCP; Megan Ranney MD MPH FACEP – Assistant Professor of Emergency Medicine and the Department of Health Services Policy and Practice at Brown University; Lauren Whiteside MD MS – Instructor in the Division of Emergency Medicine at the University of Washington; Caleb Banta-Green PhD MPH MSW – Research Scientist; Ed Bernstein MD – Professor of Emergency Medicine and Director of the Brief Negotiated Interview & Active Referral to Treatment (BNI-ART) Institute at Boston University Medical Center (BUMC).
Access the slides from the Webinar
For an overview of Naloxone access and Good Samaritan laws please visit the Network for Public Health Law at:
For information on Naloxone prescribing and overdose prevention programs, please visit:
Emergency Department Naloxone Distribution: Key Considerations and Implementation Strategies
Download TIPS White Paper PDF
For information on overdose intervention visit:
White House ONDCP: